project id: TCGA-ACC; case submitter id: TCGA-OR-A5KW; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.8; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.41; rna integrity number: 9.3; age at index: 55; days to birth: -20328; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1954; age at diagnosis: 20328; ajcc clinical m: M0; ajcc pathologic n: N1; ajcc pathologic stage: Stage III; ajcc pathologic t: T2; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 2076.0; icd 10 code: C74.0; last known disease status: not reported; morphology: 8370/3; primary diagnosis: Adrenal cortical carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cortex of adrenal gland; synchronous malignancy: No; tissue or organ of origin: Cortex of adrenal gland; tumor grade: Not Reported; year of diagnosis: 2009; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 1245; initial weight: 230.0; sample id: 0a8e38a4-7e21-4a7a-a0d4-47455f1db4cf; sample submitter id: TCGA-OR-A5KW-01A; portion id: 0672e4e5-458e-477c-9a4b-303426b12fd3; portion submitter id: TCGA-OR-A5KW-01A-11; slide id: 946f5157-a7b0-4e4a-aaf8-b1ab904c8e3d; slide submitter id: TCGA-OR-A5KW-01A-01-TSA; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 5.0; percent tumor cells: 95.0; percent tumor nuclei: 100.0; section location: TOP;